Home › Funds › Delaware/Macquarie › Nomura Small Cap Core Fund
Fund family: Delaware/Macquarie · Filed by DELAWARE GROUP EQUITY FUNDS V (CIK 809821) · SEC series S000002400
Share classes and tickers: DCCAX (C000006373), DCCCX (C000006374), DCCIX (C000006376), DCCRX (C000006375), DCZRX (C000171461)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,221 with, 2 against, 0 abstentions (not counted as with management). Shareholder proposals: 2 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Delaware/Macquarie’s manager page (15,554 ballot items across 17 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Delaware/Macquarie | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 91.8% | 1,196 | 92.2% | 13,591 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 24.8% | 266 |
Each ballot item this fund voted is set against the votes of the other Delaware/Macquarie funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Delaware/Macquarie funds on all 93 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 96.3% of this fund’s 1,223 such votes could be given a sector; the other 45 (3.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 248 | 1 | 0.4% |
| Finance | 247 | 0 | 0.0% |
| Industrials | 176 | 1 | 0.6% |
| Technology | 136 | 0 | 0.0% |
| Health Care | 134 | 0 | 0.0% |
| Real Estate | 99 | 0 | 0.0% |
| Energy | 69 | 0 | 0.0% |
| Utilities | 44 | 0 | 0.0% |
| Basic Materials | 16 | 0 | 0.0% |
| Telecommunications | 6 | 0 | 0.0% |
| Consumer Staples | 3 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 849 | 0 |
| Say-on-Pay | 153 | 0 |
| Audit-related | 137 | 0 |
| Compensation | 47 | 0 |
| Corporate Governance | 22 | 1 |
| Extraordinary Transactions | 14 | 0 |
| Capital Structure | 12 | 0 |
| Shareholder Rights and Defenses | 4 | 0 |
| Environment or Climate | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Semtech Corporation | June 4, 2026 | $156M | 12 | 0 |
| Ligand Pharmaceuticals Incorporated | June 5, 2026 | $117M | 11 | 0 |
| Silicon Laboratories Inc. | April 23, 2026 | $110M | 5 | 0 |
| Travere Therapeutics, Inc. | May 19, 2026 | $108M | 14 | 0 |
| Silicon Laboratories Inc. | April 30, 2026 | $107M | 3 | 0 |
| Glaukos Corporation | May 28, 2026 | $105M | 4 | 0 |
| Federal Signal Corporation | April 21, 2026 | $96M | 10 | 0 |
| BridgeBio Pharma, Inc. | June 22, 2026 | $88M | 7 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 24, 2026 | ArcBest Corporation | A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposal | For | Against |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
1,239 ballot items at 149 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Nomura Small Cap Core Fund (DCCAX) voted at 149 shareholder meetings of 141 companies, on 1,239 ballot items in all. Where management made a recommendation, the fund followed it on 99.8% of the items and voted against it 2 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 2 shareholder proposals. It voted FOR the board's own proposals about as often as Delaware/Macquarie's funds as a whole (91.8% against 92.2%). It voted the same way as most Delaware/Macquarie funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Delaware/Macquarie’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.